Esperion Therapeutics Inc (ESPR)
SG&A Expense Growth
4.08%
Quarterly · Period ending:
ESPR SG&A Expense Growth
Latest reported4.08%period ending
Latest reported4.08%period ending
ESPR Quarterly SG&A Growth (QoQ) (0.00% → 4.08%)
Latest values, visible window
High-resolution chart · PNG
ESPR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.0813% | |
| -0.9917% | |
| 5.9202% | |
| -8.1101% | |
| 16.4414% | |
| -7.6298% | |
| -9.5281% | |
| 5.2324% | |
| -7.5622% | |
| 36.6516% | |
| -2.1173% | |
| 13.5715% | |
| 23.8752% | |
| -3.27% | |
| -15.7216% | |
| -2.5411% | |
| -20.7549% | |
| -2.3609% | |
| -15.2273% | |
| -24.1484% | |
| -0.7977% | |
| 26.0701% | |
| 2.4014% | |
| 14.7474% | |
| 91.3826% | |
| 17.5655% | |
| 36.8811% | |
| 10.7536% | |
| 9.0014% | |
| 24.0262% | |
| 29.5428% | |
| 16.829% | |
| 13.2585% | |
| -7.4635% | |
| 4.9704% | |
| 7.6158% | |
| 14.1916% | |
| 4.5088% | |
| -9.0438% | |
| -7.911% | |
| -4.6798% | |
| -6.9464% | |
| 7.9764% | |
| 30.1859% | |
| 26.8868% | |
| 25.8907% | |
| -7.3368% | |
| 9.4779% | |
| 3.8582% | |
| 24.6004% | |
| 64.2572% | |
| -6.3923% | |
| 147.4309% | |
| -5.2585% | |
| 0.0335% | |
| -15.6101% | |
| 0% | |
| 11.9795% | |
| -4.1743% | |
| 35.1867% | |
| -28.1455% | |
| 17.437% | |
| -13.1915% | |
| 27.4206% | |
| -7.4552% | |
| 22.9075% | |
| 3.1818% | |
| 79.7386% | |
| 0.1637% | |
| -15.1389% | |
| -28.4091% | |
| 0% |